Biochemical and immunological analysis of mould skin prick test solution: Current status of standardization

Clinical and Experimental Allergy

Volumn 43, Issue 11, 2013, Pages 1286-1296

  Kespohl, S ^a   Maryska, S ^a   Zahradnik, E ^a   Sander, I ^a   Bruning T ^a   Raulf Heimsoth, M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Allergen content; Allergy; Mould allergen extracts; Skin prick test; Standardization

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ALTERNARIA ALTERNATA; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS VERSICOLOR; BIOCHEMISTRY; CLADOSPORIUM HERBARUM; IMMUNOLOGY TEST KIT; MOULD; PENICILLIUM CHRYSOGENUM; PRICK TEST; PRIORITY JOURNAL; PROTEIN CONTENT; SKIN TEST; STANDARDIZATION;

ALLERGEN CONTENT; ALLERGY; MOULD ALLERGEN EXTRACTS; SKIN PRICK TEST; STANDARDIZATION;

ALLERGENS; ANTIGENS, FUNGAL; FUNGI; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PROTEIN BINDING; REAGENT KITS, DIAGNOSTIC; SKIN TESTS;

EID: 84886233091     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12186     Document Type: Article

References (37)

1. Burbach GJ, Heinzerling LM, Edenharter G et al. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy 2009; 64:1507-15.
2. Mari A, Schneider P, Wally V, Breitenbach M, Simon-Nobbe B. Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy 2003; 33:1429-38.
3. Bousquet PJ, Castelli C, Daures JP et al. Assessment of Allergen Sensitization in a General Population-Based Survey (European Community Respiratory Health Survey I). Ann Epidemiol 2010; 20:797-803.
4. Reijula K, Leino M, Mussalo-Rauhamaa H et al. IgE-mediated allergy to fungal allergens in Finland with special reference to Alternaria alternata and Cladosporium herbarum. Ann Allergy Asthma Immunol 2003; 91:280-7.
5. Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol 2011; 49:S150-7.
6. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27:615-26.
7. Knutsen AP, Bush RK, Demain JG et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129:280-91.
8. Beezhold DH, Green BJ, Blachere FM et al. Prevalence of allergic sensitization to indoor fungi in West Virginia. Allergy Asthma Proc 2008; 29:29-34.
9. Simon-Nobbe B, Denk U, Poll V, Rid R, Breitenbach M. The spectrum of fungal allergy. Int Arch Allergy Immunol 2008; 145:58-86.
10. Fairs A, Agbetile J, Hargadon B et al. IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma. Am J Respir Crit Care Med 2010; 182:1362-8.
11. Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011; 66:679-85.
12. Denning DW, O'Driscoll BR, Powell G et al. Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization The Fungal Asthma Sensitization Trial (FAST) Study. Am J Respir Crit Care Med 2009; 179:11-8.
13. Bornehag CG, Blomquist G, Gyntelberg F et al. Dampness in buildings and health. Nordic interdisciplinary review of the scientific evidence on associations between exposure to "dampness" in buildings and health effects (NORDDAMP). Indoor Air 2001; 11:72-86.
14. Bornehag CG, Sundell J, Bonini S et al. Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. Indoor Air 2004; 14:243-57.
15. Holme J, Hagerhed-Engman L, Mattsson J, Sundell J, Bornehag CG. Culturable mold in indoor air and its association with moisture-related problems and asthma and allergy among Swedish children. Indoor Air 2010; 20:329-40.
16. Karvala K, Toskala E, Luukkonen R, Lappalainen S, Uitti J, Nordman H. New-onset adult asthma in relation to damp and moldy workplaces. Int Arch Occup Environ Health 2010; 83:855-65.
17. Benndorf D, Muller A, Bock K, Manuwald O, Herbarth O, von Bergen M. Identification of spore allergens from the indoor mould Aspergillus versicolor. Allergy 2008; 63:454-60.
18. Engelhart S, Loock A, Skutlarek D et al. Occurrence of toxigenic Aspergillus versicolor isolates and sterigmatocystin in carpet dust from damp indoor environments. Appl Environ Microbiol 2002; 68:3886-90.
19. Meklin T, Husman T, Vepsalainen A et al. Indoor air microbes and respiratory symptoms of children in moisture damaged and reference schools. Indoor Air 2002; 12:175-83.
20. Schmechel D, Simpson JP, Lewis DM. The production and characterization of monoclonal antibodies to the fungus Aspergillus versicolor. Indoor Air 2005; 15(Suppl 9):11-9.
21. O'Driscoll BR, Powell G, Chew F et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009; 39:1677-83.
22. Esch RE. Manufacturing and standardizing fungal allergen products. J Allergy Clin Immunol 2004; 113:210-5.
23. Grier TJ, Hazelhurst DM, Duncan EA, West TK, Esch RE. Major allergen measurements: sources of variability, validation, quality assurance, and utility for laboratories, manufacturers, and clinics. Allergy Asthma Proc 2002; 23:125-31.
24. Larenas-Linnemann D, Cox LS. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008; 100:137-45.
25. Larenas-Linnemann D, Esch RE, Guidos-Fogelbach G, Rodriguez-Perez N. A comparison of in vitro potency between European and Mexican allergen extracts and US (CBER/FDA) reference extracts. Allergol Immunopathol 2010; 38:170-3.
26. Reuter A, Luttkopf D, Vieths S. New frontiers in allergen standardization. Clin Exp Allergy 2009; 39:307-9.
27. Jeong KY, Hong CS, Lee JS, Park JW. Optimization of allergen standardization. Yonsei Med J 2011; 52:393-400.
28. Sander I, Zahradnik E, van Kampen V et al. Development and application of mold antigen-specific enzyme-linked immunosorbent assays (ELISA) to quantify airborne antigen exposure. J Toxicol Environ Health A 2012; 75:1185-93.
29. Blum H, Beier H, Gross HJ. Improved Silver Staining of Plant-Proteins, Rna and Dna in Polyacrylamide Gels. Electrophoresis 1987; 8:93-9.
30. Zahradnik E, Kespohl S, Sander I et al. A new immunoassay to quantify fungal antigens from the indoor mould Aspergillus versicolor. Environ Sci Process Impacts 2013; 15:1162-71.
31. Sander I, Kespohl S, Merget R et al. A new method to bind allergens for the measurement of specific IgE antibodies. Int Arch Allergy Immunol 2005; 136:39-44.
32. van Kampen V, de Blair F, Folletti I et al. EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies. Allergy 2013; 68:580-4.
33. van Ree R. The CREATE project: a new beginning of allergen standardization based on mass units of major allergens. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003; 94:70-3.
34. Vailes L, Sridhara S, Cromwell O, Weber B, Breitenbach M, Chapman M. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001; 107:641-6.
35. Ibarrola I, Suarez-Cervera M, Arilla MC et al. Production profile of the major allergen Alt a 1 in Alternaria alternata cultures. Ann Allergy Asthma Immunol 2004; 93:589-93.
36. Aden E, Weber B, Bossert J et al. Standardization of Alternaria alternata: extraction and quantification of alt a 1 by using an mAb-based 2-site binding assay. J Allergy Clin Immunol 1999; 104:128-35.
37. Arruda LK, Mann BJ, Chapman MD. Selective Expression of A Major Allergen and Cytotoxin, Asp F-I, in Aspergillus-Fumigatus - Implications for the Immunopathogenesis of Aspergillus-Related Diseases. J Immunol 1992; 149:3354-9.